About

Dr. Robert J. Alpern serves as an independent director of Abbott Laboratories, drawing on decades of leadership in academic medicine, most notably his long tenure as Dean of the Yale School of Medicine.

His medical and scientific expertise and his knowledge of the health care environment inform the Board's oversight of Abbott's research and development. He is not standing for re-election at the 2026 Annual Meeting and will continue to serve as a director until that meeting.

Roles

Abbott Laboratories
Director · Current role
Present
Yale School of Medicine
Dean and Ensign Professor of Medicine · A long-tenured leadership position in academic medicine.
2004 onward
The University of Texas Southwestern Medical Center
Dean
July 1998 to June 2004
The University of Texas Southwestern Medical Center
Chief of the Division of Nephrology and Professor of Internal Medicine · Held the Ruth W. and Milton P. Levy, Sr. Chair in Molecular Nephrology and the Atticus James Gill, M.D. Chair in Medical Science.
1987 onward
Yale School of Medicine
Dean
2004 to present
The University of Texas Southwestern Medical Center
Associate Professor and Chief of the Division of Nephrology · Also served as Professor of Internal Medicine and held the Ruth W. and Milton P. Levy, Sr. Chair in Molecular Nephrology and the Atticus James Gill, M.D. Chair in Medical Science.
1987 onward

External Roles

Yale New Haven Hospital
Board of Directors member
October 2005 to January 2020
Relypsa, Inc.
Scientific Advisory Board member
2007 onward
Ilypsa, Inc.
Scientific Advisory Board member
2004 to 2007
Relypsa
Scientific Advisory Board member
2007 onward
Ilypsa
Scientific Advisory Board member
2004 to 2007

Director Compensation

FY 2025
Fees earned or paid in cash
$126,000
Stock awards
$209,906
Change in pension value and nonqualified deferred compensation earnings
$112,585
All other compensation
$25,000
Total
$473,491

Also at Abbott Laboratories

Related

See how VectorShift works for your firm

Request Demo